Clinical Trial

PK and PD Study of NPI-001 and Cysteamine Bitartrate

Name: PK and PD Study of NPI-001 and Cysteamine Bitartrate — clinical trial record (NCT05994534)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: INCA

Active, Not Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

Safety, pharmacokinetics, and pharmacodynamics of NPI-001 oral solution in cystinosis patients compared with cysteamine.

Protocol Amendment History 2 changes

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-01

notable Primary completion pushed: 2026-06 -> 2026-08 2026-07-01

Trial Details

NCT Number	NCT05994534
Lead Sponsor	Nacuity Pharmaceuticals, Inc.
Conditions	Cystinosis
Enrollment	12 participants
Start Date	2023-10-29
Primary Completion	2026-08 (estimated)
Study Completion	2026-08 (estimated)
Updated on ClinicalTrials.gov	2026-06-30